BCWM
DNLI icon

Bartlett & Co Wealth Management’s Denali Therapeutics DNLI Stock Holding History

Bartlett & Co Wealth Management’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.6K Hold
1,500
– – ﹤0.01% 788
2026
Q1 		$28K Hold
1,500
– – ﹤0.01% 769
2025
Q4 		$24.8K Hold
1,500
– – ﹤0.01% 785
2025
Q3 		$21.8K Hold
1,500
– – ﹤0.01% 812
2025
Q2 		$21K Hold
1,500
– – ﹤0.01% 805
2025
Q1 		$20.4K Hold
1,500
– – ﹤0.01% 810
2024
Q4 		$30.6K Hold
1,500
– – ﹤0.01% 736
2024
Q3 		$43.7K Hold
1,500
– – ﹤0.01% 678
2024
Q2 		$34.8K Hold
1,500
– – ﹤0.01% 726
2024
Q1 		$30.8K Hold
1,500
– – ﹤0.01% 740
2023
Q4 		$32.9K Sell
1,500
-23,300
-94% -$461K ﹤0.01% 774
2023
Q3 		$512K Buy
24,800
+3,260
+15% +$82.7K 0.01% 331
2023
Q2 		$636K Hold
21,540
– – 0.01% 311
2023
Q1 		$496K Buy
21,540
+760
+4% +$20.9K 0.01% 292
2022
Q4 		$578K Hold
20,780
– – 0.01% 274
2022
Q3 		$638K Buy
20,780
+2,269
+12% +$73.8K 0.01% 250
2022
Q2 		$545K Buy
18,511
+1
+0% +$26 0.01% 276
2022
Q1 		$595K Buy
18,510
+1,567
+9% +$53.9K 0.01% 279
2021
Q4 		$756K Buy
16,943
+15,443
+1,030% +$732K 0.01% 250
2021
Q3 		$75.7K Hold
1,500
– – ﹤0.01% 454
2021
Q2 		$118K Hold
1,500
– – ﹤0.01% 391
2021
Q1 		$85.7K Sell
1,500
-500
-25% -$33.5K ﹤0.01% 448
2020
Q4 		$168K Buy
+2,000
New +$121K ﹤0.01% 342

Other funds holding DNLI

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bartlett & Co Wealth Management's DNLI Position: Q2 2026 in Review

Bartlett & Co Wealth Management held its Denali Therapeutics (DNLI) position steady in Q2 2026 at 1,500 shares worth $38.6K. The position accounts for ﹤0.01% of the portfolio, ranked #788.

Bartlett & Co Wealth Management first reported a position in DNLI in Q4 2020 and has held it in 23 quarters since. The position peaked at $756K in Q4 2021. 292 funds tracked by Wall St. Rank hold DNLI as of Q2 2026.

  • Bartlett & Co Wealth Management held 1,500 shares of Denali Therapeutics worth $38.6K as of Q2 2026.
  • Bartlett & Co Wealth Management left its Denali Therapeutics share count unchanged in Q2 2026.
  • Denali Therapeutics made up ﹤0.01% of Bartlett & Co Wealth Management's portfolio in Q2 2026, its #788 holding.
  • Bartlett & Co Wealth Management first reported a position in Denali Therapeutics in Q4 2020 and has held it in 23 quarters since.
  • Bartlett & Co Wealth Management's Denali Therapeutics position peaked at $756K in Q4 2021.
  • 292 funds tracked by Wall St. Rank held Denali Therapeutics as of Q2 2026.

Based on Bartlett & Co Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.